Form 4: Alphatec Director Sells 200,000 Shares Under 10b5-1 Plan

Alphatec Holdings, Inc. Director Jeffrey P. Rydin sold 200,000 shares of common stock for $19.32 per share on November 3, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Jeffrey P. Rydin, a Director of Alphatec Holdings, Inc. (ATEC), reported a sale of common stock.
• The transaction involved the disposition of 200,000 shares of common stock.
• The shares were sold at a price of $19.32 per share.
• The total value of the transaction was $3,864,000.
• The sale occurred on November 3, 2025.
• The transaction was made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.
• Following this transaction, Mr. Rydin beneficially owns 385,441 shares of Alphatec Holdings, Inc. common stock directly.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While an insider sale can sometimes be viewed negatively, the fact that it was executed under a Rule 10b5-1 plan suggests a pre-scheduled personal financial management decision rather than a reflection of immediate negative sentiment about the company's prospects. The filing provides no other operational or financial information to sway sentiment.

Positives

• The sale was conducted under a Rule 10b5-1 plan, indicating it was pre-scheduled and not necessarily based on immediate insider sentiment regarding the company's prospects.

Negatives

• A significant insider sale of 200,000 shares by a director could be perceived negatively by some investors, despite being pre-planned.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

Insider transactions, such as this director's sale, are a routine part of market activity. While a large sale can sometimes draw attention, the context of a Rule 10b5-1 plan suggests a pre-arranged financial management strategy rather than a reaction to immediate company-specific news or industry trends. The medical technology and spine surgery industry, in which Alphatec operates, continues to see innovation and competitive dynamics, but this filing does not provide specific industry-related insights.

Stakeholder Impact

• Shareholders may observe the director's sale and consider its implications, though the 10b5-1 plan mitigates concerns about immediate insider sentiment.

Key Dates

Recommendation

A single insider sale, even of a significant volume, by a director under a pre-arranged Rule 10b5-1 plan does not typically warrant a change in investment recommendation without additional context. Such plans are often for personal financial diversification or liquidity and are not necessarily indicative of a change in the company's fundamental outlook. Investors should 'hold' and monitor future company performance and broader market conditions rather than reacting solely to this transaction.

Keywords

Alphatec Holdings, ATEC, Jeffrey P. Rydin, Insider Trading, Form 4, Stock Sale, Director, 10b5-1 Plan, Common Stock